Gene · 4300
Papers2,395
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,395
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting the Menin-KMT2A interaction in leukemia: Lessons learned and future directions. | Int J Cancer | 2026 | 39887730 | PubTator, text mining | PubMed |
| Development of a Multilayered Prognostic Model for Wilms' Tumor Based on Characteristic Lymphocyte Genes. | Genet Res (Camb) | 2025 | 41438620 | PubTator, text mining | PubMed |
| Thrombopoietin increases susceptibility for EVI1 + KMT2A-MLLT3-driven AML expressing stem cell genes linked to poor outcome. | Nat Commun | 2025 | 41419472 | PubTator, text mining | PubMed |
| Unraveling hematopoietic stem cell ontogeny through single-cell multi-omics approaches. | Front Cell Dev Biol | 2025 | 41358001 | PubTator, text mining | PubMed |
| Retraction Note: miR-564 inhibited metastasis and proliferation of prostate cancer by targeting MLLT3. | Eur Rev Med Pharmacol Sci | 2025 | 41182308 | PubTator, text mining | PubMed |
| KMT2A alterations in acute myeloid leukemia: a proposed genetic risk model and transplantation outcomes. | Exp Hematol Oncol | 2025 | 41121446 | PubTator, text mining | PubMed |
| Differentiation latency and dormancy signatures define fetal liver hematopoietic stem cells at single-cell resolution. | Cell Rep | 2025 | 40971295 | PubTator, text mining | PubMed |
| A chemical-genetic interaction between PAF1 and ENL/AF9 YEATS inhibition. | bioRxiv | 2025 | 40964345 | PubTator, text mining | PubMed |
| [Non-Down-syndrome-related acute megakaryoblastic leukemia in children: a clinical analysis of 17 cases]. | Zhongguo Dang Dai Er Ke Za Zhi | 2025 | 40962523 | PubTator, text mining | PubMed |
| Synthesis, Structure-Activity Relationships, and Antitumor Activities of Quinoxiline-Containing Inhibitors of the Protein-Protein Interactions between Transcription Coactivator AF9/ENL and DOT1L/AF4. | J Med Chem | 2025 | 40957087 | PubTator, text mining | PubMed |
| The MLLT3 YEATS domain is a dual reader of histone marks (H3K9/18/27ac/cr) and ncRNA (7SK), linking epigenetic and RNA signaling to regulate hematopoiesis. | bioRxiv | 2025 | 40950097 | PubTator, text mining | PubMed |
| The lncRNA ELDR suppresses tumorigenicity of AML by interfering with DNA replication and chromatin accessibility. | Blood Adv | 2025 | 40921006 | PubTator, text mining | PubMed |
| Multi-omics analysis identifies an M-MDSC-like immunosuppressive phenotype in lineage-switched AML with KMT2A rearrangement. | Nat Commun | 2025 | 40858576 | PubTator, text mining | PubMed |
| Newly diagnosed acute myeloid leukemia in unfit patients: 2026 treatment algorithms. | Blood Cancer J | 2025 | 40818987 | PubTator, text mining | PubMed |
| FTO degrader impairs ribosome biogenesis and protein translation in acute myeloid leukemia. | Sci Adv | 2025 | 40815637 | PubTator, text mining | PubMed |
| Energy Deficiency-Induced ATG4B Nuclear Translocation Inhibits PRMT1-Mediated DNA Repair and Promotes Leukemia Progression. | Adv Sci (Weinh) | 2025 | 40788108 | PubTator, text mining | PubMed |
| Epigenetic regulation of cancer stemness. | Signal Transduct Target Ther | 2025 | 40744921 | PubTator, text mining | PubMed |
| Cytogenetic landscape aberrations in paediatric acute lymphoblastic leukaemia - a polish paediatric population treated according to ALL-IC BFM 2009 protocol. | Sci Rep | 2025 | 40731127 | PubTator, text mining | PubMed |
| A Systematic, Evidence-Based Workflow for Classifying KMT2A Fusions in Acute Myeloid Leukemia. | J Mol Diagn | 2025 | 40706988 | PubTator, text mining | PubMed |
| Development of Chemical Tools for the Human YEATS Domain. | ACS Chem Biol | 2025 | 40643381 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4300/papers?page=3